彪马生物技术 PBYI 深 沪
交易中 04-01 12:02:10 美东时间
6.7999
+0.410
+6.41%
华盛通- 最 高6.7999
- 今 开6.47
- 成交量 11.57万股
- 最 低 6.455
- 昨 收 6.39
- 总市值 3.46亿
- 52周最高 7.68
- 市盈率 静 11.07
- 换手率 0.23%
- 52周最低 2.75
- 委 比 8.89%
- 总股本 5087.65万
- 历史最高 279.37
- 量 比 1.56
- 振 幅 5.40%
- 历史最低 1.60
- 每 手 1
- 风险率 1.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多UPDATE: Puma Biotechnology Sees FY2026 Sales $214.000M-$221.000M vs $220.000M Est
Puma Biotechnology (NASDAQ:PBYI) sees FY2026 sales of $214.000 million-$221.000 million vs $220.000 million analyst estimate.
02-27 07:58
UPDATE: Puma Biotechnology Q4 Adj. EPS $0.29 Beats $0.23 Estimate, Sales $75.500M Beat $68.600M Estimate
Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.23 by 27.75 percent. This is a 32.56 percent decrease over earnings of $0.43 per share from
02-27 07:09
Puma Biotechnology shares are trading lower after the company reported Q4 financial results and issued Q1 sales guidance below estimates. Also, the company issued FY26 sales guidance with its midpoint below estimates.
Puma Biotechnology shares are trading lower after the company reported Q4 finan...
02-27 05:13
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Puma Biotechnology Added To Nasdaq Biotechnology Index, Effective Dec. 19
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that it has been added to the Nasdaq Biotechnology Index (NASDAQ:NBI), effective at the close of trading on Friday, December 19, 2025.
2025-12-23 05:11
Puma Biotechnology shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q3 sales guidance above estimates. Also, the company raised its FY25 sales guidance above estimates.
Puma Biotechnology shares are trading higher after the company reported better-...
2025-11-08 00:15
美股牛股 | 特朗普重新分类大麻危险等级消息引爆市场，Tilray飙升超过41%
特朗普重新分类大麻危险等级消息引爆市场，Tilray飙升超过41%；Q2业绩超市场预期，Telos Corporation隔夜飙升超60%>>
2025-08-12 14:45
Puma Biotechnology Affirms FY2025 Sales Guidance of $212.000M-$222.000M vs $217.800M Est
Puma Biotechnology (NASDAQ:PBYI) affirms FY2025 sales outlook from $212.000 million-$222.000 million to $212.000 million-$222.000 million vs $217.800 million estimate.
2025-08-08 04:28
Puma Biotechnology’s Earnings Call: A Mixed Bag
Puma Biotechnology (($PBYI)) has held its Q1 earnings call. Read on for the mai...
2025-05-10 08:21
Puma Biotechnology Terminates Chief Commercial Officer
Puma Biotechnology ( ($PBYI) ) has shared an announcement. On May 8, 2025, Puma...
2025-05-09 21:18
